Molecular genetics of Xeroderma pigmentosum variant

Abstract:  Xeroderma pigmentosum (XP) is an autosomal recessive disease characterized by sun sensitivity, early onset of freckling and subsequent neoplastic changes on sun‐exposed skin. Skin abnormalities result from an inability to repair UV‐damaged DNA because of defects in the nucleotide excision repair (NER) machinery. Xeroderma pigmentosum is genetically heterogeneous and is classified into seven complementation groups (XPA‐XPG) that correspond to genetic alterations in one of seven genes involved in NER. The variant type of XP (XPV), first described in 1970 by Ernst G. Jung as ‘pigmented xerodermoid’, is caused by defects in the post replication repair machinery while NER is not impaired. Identification of the XPV gene was only achieved in 1999 by biochemical purification and sequencing of a protein from HeLa cell extracts complementing the PRR defect in XPV cells. The XPV protein, polymerase (pol)η, represents a novel member of the Y family of bypass DNA polymerases that facilitate DNA translesion synthesis. The major function of polη is to allow DNA translesion synthesis of UV‐induced TT‐dimers in an error‐free manner; it also possesses the capability to bypass other DNA lesions in an error‐prone manner. Xeroderma pigmentosum V is caused by molecular alterations in the POLH gene, located on chromosome 6p21.1–6p12. Affected individuals are homozygous or compound heterozygous for a spectrum of genetic lesions, including nonsense mutations, deletions or insertions, confirming the autosomal recessive nature of the condition. Identification of POLH as the XPV gene provides an important instrument for improving molecular diagnostics in XPV families.

[1]  A. Sarasin,et al.  Molecular analysis of mutations in DNA polymerase η in xeroderma pigmentosum-variant patients , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Woodgate,et al.  Crystal Structure of a Y-Family DNA Polymerase in Action A Mechanism for Error-Prone and Lesion-Bypass Replication , 2001, Cell.

[3]  Robert E. Johnson,et al.  Structure of the catalytic core of S. cerevisiae DNA polymerase eta: implications for translesion DNA synthesis. , 2001, Molecular cell.

[4]  T. Steitz,et al.  Crystal structure of a DinB lesion bypass DNA polymerase catalytic fragment reveals a classic polymerase catalytic domain. , 2001, Molecular cell.

[5]  T. Kunkel,et al.  The Y-family of DNA polymerases. , 2001, Molecular cell.

[6]  L. Mullenders,et al.  Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. , 2001, Genes & development.

[7]  M. Yamaizumi,et al.  Xeroderma pigmentosum variant heterozygotes show reduced levels of recovery of replicative DNA synthesis in the presence of caffeine after ultraviolet irradiation. , 2000, The Journal of investigative dermatology.

[8]  Yanbin Zhang,et al.  Error-prone lesion bypass by human DNA polymerase eta. , 2000, Nucleic acids research.

[9]  L. Prakash,et al.  Replication pastO6-Methylguanine by Yeast and Human DNA Polymerase η , 2000, Molecular and Cellular Biology.

[10]  T. Eki,et al.  Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene , 2000, Oncogene.

[11]  Robert E. Johnson,et al.  Efficient and accurate replication in the presence of 7,8-dihydro-8-oxoguanine by DNA polymerase η , 2000, Nature Genetics.

[12]  F. Hanaoka,et al.  Error-prone bypass of certain DNA lesions by the human DNA polymerase kappa. , 2000, Genes & development.

[13]  F. Hanaoka,et al.  Mechanisms of accurate translesion synthesis by human DNA polymerase η , 2000, The EMBO journal.

[14]  Satya Prakash,et al.  Fidelity of Human DNA Polymerase η* , 2000, The Journal of Biological Chemistry.

[15]  Fenghua Yuan,et al.  Specificity of DNA Lesion Bypass by the Yeast DNA Polymerase η* , 2000, The Journal of Biological Chemistry.

[16]  H. Nasheuer,et al.  Eukaryotic DNA polymerases, a growing family. , 2000, Trends in biochemical sciences.

[17]  Yanbin Zhang,et al.  The human REV1 gene codes for a DNA template-dependent dCMP transferase. , 1999, Nucleic acids research.

[18]  Robert E. Johnson,et al.  Bridging the gap: a family of novel DNA polymerases that replicate faulty DNA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  E. Koonin,et al.  Human and mouse homologs of Escherichia coli DinB (DNA polymerase IV), members of the UmuC/DinB superfamily. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Epstein,et al.  Novel human and mouse homologs of Saccharomyces cerevisiae DNA polymerase eta. , 1999, Genomics.

[21]  Robert E. Johnson,et al.  hRAD30 mutations in the variant form of xeroderma pigmentosum. , 1999, Science.

[22]  Chikahide Masutani,et al.  The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η , 1999, Nature.

[23]  F. Hanaoka,et al.  Xeroderma pigmentosum variant (XP‐V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity , 1999, The EMBO journal.

[24]  A. Lehmann,et al.  Impaired Translesion Synthesis in Xeroderma Pigmentosum Variant Extracts Xeroderma Pigmentosum Variant Extracts Impaired Translesion Synthesis In , 2022 .

[25]  J. Taylor,et al.  Bypass of a site-specific cis-Syn thymine dimer in an SV40 vector during in vitro replication by HeLa and XPV cell-free extracts. , 1998, Biochemistry.

[26]  J. Vos,et al.  Defective bypass replication of a leading strand cyclobutane thymine dimer in xeroderma pigmentosum variant cell extracts. , 1998, Cancer Research.

[27]  J P McDonald,et al.  Is Dna Damage Inducible and Functions in a Novel Error-free Postreplication Repair Mechanism , 1997 .

[28]  W. Kaufmann,et al.  Replication Fork Bypass of a Pyrimidine Dimer Blocking Leading Strand DNA Synthesis* , 1997, The Journal of Biological Chemistry.

[29]  H. Ohmori,et al.  dinP, a new gene in Escherichia coli, whose product shows similarities to UmuC and its homologues. , 1995, Mutation research.

[30]  F. Larimer,et al.  The REV1 gene of Saccharomyces cerevisiae: isolation, sequence, and functional analysis , 1989, Journal of bacteriology.

[31]  C. Nishigori,et al.  Genetics and skin cancer of xeroderma pigmentosum in Japan. , 1987, Japanese journal of cancer research : Gann.

[32]  K. Kraemer,et al.  Xeroderma Pigmentosum: Cutaneous, Ocular, and Neurologic Abnormalities in 830 Published Cases , 1987 .

[33]  H. Takebe,et al.  Neurological manifestations in xeroderma pigmentosum , 1986, Annals of neurology.

[34]  W. Kaufmann,et al.  Similar defects in DNA repair and replication in the pigmented xerodermoid and the xeroderma pigmentosum variants. , 1980, Carcinogenesis.

[35]  Takesi Kato,et al.  Isolation and characterization of mutants of Escherichia coli deficient in induction of mutations by ultraviolet light , 1977, Molecular and General Genetics MGG.

[36]  A. Lehmann,et al.  Repair of ultraviolet light damage in a variety of human fibroblast cell strains. , 1977, Cancer research.

[37]  B. Flaxman,et al.  DNA repair in tumor cells from the variant form of xeroderma pigmentosum. , 1975, The Journal of investigative dermatology.

[38]  R. Happle.  [Case demonstration: Pigmented xerodermoid]. , 1974, Zeitschrift fur Hautkrankheiten.

[39]  K. Kraemer,et al.  Xeroderma Pigmentosum: An Inherited Disease with Sun Sensitivity, Multiple Cutaneous Neoplasms, and Abnormal DNA Repair , 1974 .

[40]  E. Jung,et al.  Xeroderma pigmentosum and pigmented xerodermoid. , 1971, Birth defects original article series.

[41]  M. Lutzner,et al.  Ultraviolet-stimulated thymidine incorporation in xeroderma pigmentosum lymphocytes. , 1971, The Journal of laboratory and clinical medicine.

[42]  E. Jung.  New Form of Molecular Defect in Xeroderma Pigmentosum , 1970, Nature.

[43]  E. Jung,et al.  Pigmented xerodermoid and XP-variants , 2004, Archives of Dermatological Research.

[44]  J. Utikal,et al.  Chromosome 7 aneusomy. A marker for metastatic melanoma? Expression of the epidermal growth factor receptor gene and chromosome 7 aneusomy in nevi, primary malignant melanomas and metastases. , 2001, Neoplasia.

[45]  O. Le Saux,et al.  [The molecular genetics of pseudoxanthoma elasticum]. , 2001, Annales de dermatologie et de venereologie.

[46]  L. Prakash,et al.  Replication past O-Methylguanine by Yeast and Human DNA Polymerase h , 2000 .

[47]  L. Prakash,et al.  Fidelity of human DNA polymerase eta. , 2000, The Journal of biological chemistry.

[48]  L. Prakash,et al.  Efficient and accurate replication in the presence of 7,8-dihydro-8-oxoguanine by DNA polymerase eta. , 2000, Nature genetics.

[49]  L. Thompson,et al.  A summary of mutations in the UV‐sensitive disorders: Xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy , 1999, Human mutation.

[50]  J. Hoeijmakers,et al.  The genetic basis of xeroderma pigmentosum. , 1991, Annales de genetique.

[51]  E. Jung,et al.  Pigmented Xerodermoid: first report of a family. , 1978, Bulletin du cancer.

[52]  Jung Eg.  Xeroderma pigmentosum: heterogeneous syndrome and model for UV carcinogenesis. , 1978 .

[53]  E. Jung.  Xeroderma pigmentosum: heterogeneous syndrome and model for UV carcinogenesis. , 1978, Bulletin du cancer.